The Joint Corp.

The Joint Corp. reported FY 2025 total revenues of $54.9 million, representing a year-over-year increase from $52.2 million in FY 2024. The company achieved net income of $2.9 million, a significant improvement from a net loss of $5.8 million in the prior year. This profitability was primarily driven by a $3.2 million net income from discontinued operations related to the corporate clinic divestiture strategy, while continuing operations reported a net loss of $268K. Gross profit was $43.7 million with a gross margin of 79.6%. Operating cash flow was positive at $1.8 million, supported by proceeds from clinic sales of $7.8 million. The company's strategic shift to refranchise company-owned clinics represents a major operational change with forward-looking implications for the franchise-focused business model.

Key Takeaways